Private Trust Co. NA Sells 317 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Private Trust Co. NA trimmed its stake in ICU Medical, Inc. (NASDAQ:ICUI) by 21.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,168 shares of the medical instruments supplier’s stock after selling 317 shares during the period. Private Trust Co. NA’s holdings in ICU Medical were worth $213,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Cerity Partners LLC increased its holdings in shares of ICU Medical by 33.2% during the third quarter. Cerity Partners LLC now owns 9,846 shares of the medical instruments supplier’s stock worth $1,794,000 after buying an additional 2,454 shares in the last quarter. Citigroup Inc. grew its position in ICU Medical by 100.4% during the 3rd quarter. Citigroup Inc. now owns 28,965 shares of the medical instruments supplier’s stock worth $5,278,000 after acquiring an additional 14,512 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in ICU Medical by 10.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 301,107 shares of the medical instruments supplier’s stock valued at $54,868,000 after purchasing an additional 27,927 shares in the last quarter. Intech Investment Management LLC bought a new position in ICU Medical in the 3rd quarter valued at $815,000. Finally, LMR Partners LLP acquired a new position in ICU Medical in the third quarter worth $3,884,000. 96.10% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

ICUI has been the subject of a number of research reports. Jefferies Financial Group initiated coverage on ICU Medical in a research note on Monday, October 14th. They issued a “hold” rating and a $183.00 target price for the company. Raymond James boosted their target price on shares of ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research note on Thursday, September 12th. Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. KeyCorp boosted their price objective on shares of ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 13th. Finally, StockNews.com upgraded ICU Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, November 20th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, ICU Medical currently has a consensus rating of “Moderate Buy” and an average price target of $173.00.

Insiders Place Their Bets

In related news, CEO Vivek Jain sold 12,000 shares of the stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $178.46, for a total value of $2,141,520.00. Following the sale, the chief executive officer now directly owns 104,593 shares in the company, valued at $18,665,666.78. This trade represents a 10.29 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, COO Christian B. Voigtlander sold 1,430 shares of the business’s stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $158.00, for a total transaction of $225,940.00. The disclosure for this sale can be found here. In the last 90 days, insiders sold 40,364 shares of company stock valued at $6,876,478. Company insiders own 6.70% of the company’s stock.

ICU Medical Trading Up 1.3 %

ICUI opened at $159.75 on Friday. The firm has a 50 day simple moving average of $175.28 and a 200 day simple moving average of $146.60. ICU Medical, Inc. has a fifty-two week low of $83.26 and a fifty-two week high of $196.26. The company has a market cap of $3.91 billion, a price-to-earnings ratio of -34.96 and a beta of 0.66. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.